pSivida Corp: BrachySil™ Phase IIb Pancreatic Cancer Trials Commence

News   Jul 08, 2008

 
pSivida Corp: BrachySil™ Phase IIb Pancreatic Cancer Trials Commence
 
 
 

RELATED ARTICLES

Abzena Selects Sartorius Stedim Biotech to Equip its US Based Development and Manufacturing Sites

News

Abzena plc, the life sciences group providing services and technologies to enable the development and manufacture of biopharmaceutical products, has selected Sartorius Stedim Biotech as its preferred equipment supplier in the U.S.

READ MORE

CBD Significantly Reduces Seizures in Patients with Severe Form of Epilepsy

News

Large-scale clinical trial finds cannabidiol can dramatically reduce the number of dangerous seizures in patients with a severe form of epilepsy called Lennox–Gastaut syndrome.

READ MORE

Drug Combo Prevents Stroke, Shows Promise for Clinic

News

Taking the clot-preventing drug clopidogrel along with aspirin may lower your risk of having a major stroke within the next 90 days following a TIA

READ MORE

 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE